# Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions

> **NCT06762743** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Epilepsy (treatment Refractory)

## Interventions

- **DRUG:** Brivaracetam Oral Solution (Test Formulation)
- **DRUG:** Brivaracetam Oral Solution (Reference Formulation)

## Key facts

- **NCT ID:** NCT06762743
- **Lead sponsor:** Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-10-21
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-01-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06762743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06762743, "Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06762743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*